MediciNova

$5.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
$0.00 (0.00%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell MediciNova and other stocks, options, and ETFs commission-free!

About MNOV

Medicinova Inc Common Stock, also called MediciNova, is a biopharmaceutical company, which engages in the acquisition and development of small molecule therapeutics for the treatment of serious diseases for the treatment of diseases with unmet medical need. Its development pipeline consists of clinical-stage compounds for the treatment of acute exacerbations of asthma and COPD, progressive multiple sclerosis, methamphetamine addiction, neuropathic pain, asthma, interstitial cystitis, and solid tumor cancers. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA. The listed name for MNOV is Medicinova Inc Common Stock.

CEO
Yuichi Iwaki
Employees
8
Headquarters
La Jolla, California
Founded
2000
Market Cap
265.97M
Price-Earnings Ratio
Dividend Yield
Average Volume
181.68K
High Today
$6.11
Low Today
$5.88
Open Price
$6.10
Volume
228.63K
52 Week High
$13.25
52 Week Low
$2.79

Collections

MNOV Earnings

-$0.14
-$0.09
-$0.05
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 11, After Hours

You May Also Like